DOI:

Tryton Side-Branch Stent

Aaron V. Kaplan1,2*, M.D; H. Richard Davis2

Description

The Tryton Side-Branch Stent™ is a slotted tube balloon deployable stent with a modular design comprise of three zones: Distal (Side-Branch) Zone, Central (Transition) Zone and Proximal (Main Vessel) Zone (Figure 1).

Figure 1. Schematic representing the Tryton Side-Branch Stent showing three zones: Distal (Side-Branch) Zone, Central (Transition) Zone and Proximal (Main Vessel) Zone. When positioned correctly within the vasculture the Side-Branch Zone resides in the side-branch, Transition Zone at the side-branch origin and the Main Vessel Zone in the main vessel proximal to the side-branch origin.

Tryton performs like a standard high-performance workhorse stent, i.e., balloon expandable, tracking over a single wire and axially oriented without the need for rotational orientation. The Tryton is simply tracked over a guidewire placed in the side-branch, such that the transition zone is at the side-branch origin. To insure precise delivery, the Tryton Side-Branch Stent is mounted on a balloon with four shaft markers, 2 standard proximal/distal stent markers, and 2 additional markers delineating the Transition Zone. The Tryton Stent is deployed after which the guidewire initially placed in the side-branch is repositioned into the distal main vessel. The Tryton stent is compatible with any standard workhorse stent (bare metal or DES), which is tracked into the Main Vessel Zone of the Tryton Stent and between specially designed fronds exiting into the distal main vessel stent (Figure 2).

Figure 2. Schematic representing the spacial relationship between the Tryton Side-Branch Stent (deployed) with an undeployed main vessel stent. The distal end of the main vessel stent has been tracked through the proximal Main Vessel Zone of the Tryton Stent, between the specially designed fronds and into the distal main vessel.

The main vessel stent is deployed after which a kissing balloon inflation is performed. Employing this strategy provides a means to definitively treat bifurcation lesions with similar coverage and hoop strength currently available with state of the art stents used in straight lesions (Figure 3).

Figure 3. Photograph of a Tryton Side-Branch Stent deployed in a plexiglass model in combination with a Cypher Stent (Cordis/ Johnson&Johnson, Miami, FL) using the protocol outlined within main text.

History

Tryton Medical, Inc. is a privately held company with offices in Newton, Massachusetts, USA founded to develop devices to treat bifurcation lesions within the coronary, cerebral and peripheral circulations.

Volume 2 Number 2
Aug 20, 2006
Volume 2 Number 2
View full issue


Key metrics

Suggested by Cory

Editorial

10.4244/EIJ-E-24-00061 Mar 3, 2025
CIED and tricuspid regurgitation – a LEADing problem?
Andreas M et al
free

Editorial

10.4244/EIJ-E-25-00006 Mar 3, 2025
Tricuspid annuloplasty: a piece of the puzzle or the whole picture?
Nickenig G and Vogelhuber J
free

Editorial

10.4244/EIJ-E-24-00074 Mar 3, 2025
Access site closure after TAVI: invincible sutures
Abdel-Wahab M and Dumpies O
free

Flashlight

10.4244/EIJ-D-24-00816 Mar 3, 2025
Double mitral and tricuspid transcatheter valve replacement
Leurent G et al

Original Research

10.4244/EIJ-D-23-01033 Mar 3, 2025
Outcomes of tricuspid transcatheter edge-to-edge repair in subjects with endocardial leads
Goebel B et al

Original Research

10.4244/EIJ-D-24-00120 Mar 3, 2025
A propensity-matched comparison of plug- versus suture-based vascular closure after TAVI
Grundmann D et al

Research Correspondence

10.4244/EIJ-D-24-00741 Mar 3, 2025
Balloon-expandable SAPIEN 3 Ultra valve in intermediate sizing zones: insights from the OPERA-TAVI registry
Costa G et al
Trending articles
200.45

State-of-the-Art

10.4244/EIJ-D-21-00089 Jun 11, 2021
Intracoronary optical coherence tomography: state of the art and future directions
Ali ZA et al
free
92.95

State-of-the-Art Review

10.4244/EIJ-D-20-01296 Aug 27, 2021
Management of cardiogenic shock
Thiele H et al
free
54

State-of-the-Art

10.4244/EIJ-D-24-00386 Feb 3, 2025
Mechanical circulatory support for complex, high-risk percutaneous coronary intervention
Ferro E et al
free
36.5

State-of-the-Art

10.4244/EIJ-D-23-00448 Jan 15, 2024
Coronary spasm and vasomotor dysfunction as a cause of MINOCA
Yaker ZS et al
free
33.8

Translational research

10.4244/EIJ-D-23-00308 Nov 17, 2023
Redo-TAVI with SAPIEN 3 in SAPIEN XT or SAPIEN 3 – impact of pre- and post-dilatation on final THV expansion
Meier D et al
free
22.55

CLINICAL RESEARCH

10.4244/EIJV12I5A93 Aug 5, 2016
Longer pre-hospital delays and higher mortality in women with STEMI: the e-MUST Registry
Benamer H et al
free
22.55

INTERVENTIONAL FLASHLIGHT

10.4244/EIJ-D-17-00774 Oct 19, 2018
Ultra-low contrast percutaneous coronary intervention in patients with severe chronic kidney disease
Azzalini L et al
free
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 7.6
2023 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2024)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2025 Europa Group - All rights reserved